CBS Genotype

A single inherited variant in the CBS gene can shape how your body handles homocysteine for your entire life. Some versions of this gene quietly lower your homocysteine, others nudge stroke or sepsis risk upward, and a rare few cause a serious metabolic condition called homocystinuria that drives early heart attacks, blood clots, and developmental problems if missed.

This is one test you take once. The result does not change, but it can change how aggressively you watch your homocysteine, your B vitamin status, and your clot risk for the rest of your life.

What CBS Actually Does

CBS (cystathionine beta-synthase) is the gene that makes an enzyme of the same name. The enzyme's job is to take homocysteine, a leftover from how your body uses protein, and convert it into something safer that gets recycled or excreted. When the enzyme works well, homocysteine stays low. When the enzyme is impaired, homocysteine builds up in the blood and damages blood vessels, the brain, and connective tissue over years.

Genetic testing of CBS reads the specific letters of DNA at this gene. The result is a fixed report of which variants you carry. It does not measure how much enzyme you have today or how much homocysteine is in your blood right now, which is why CBS genotyping is usually paired with a homocysteine blood test.

The Most Common CBS Variants and What They Mean

CBS variants fall into three buckets: common variants that are usually harmless or even mildly protective, polymorphisms that can modify disease risk in specific situations, and rare loss-of-function mutations that cause homocystinuria.

• 844ins68 (a 68-letter insertion): common in the general population, present in around 4 to 12 percent of chromosomes. Despite looking like a major change in the gene, the body splices it out, so enzyme activity stays normal. Heterozygous carriers actually had lower homocysteine after a methionine challenge in a study of about a thousand adults.
• 833T>C (I278T): the most common pathogenic CBS variant globally, accounting for roughly a quarter of all disease-causing variants, and the one that most often causes classical homocystinuria when inherited from both parents. People with two copies often respond to high-dose vitamin B6, making their disease milder than other forms.
• 699C>T and the promoter STR: linked to modest changes in homocysteine, betaine, and cystathionine concentrations in a population study of more than 10,000 adults, but not clearly tied to arterial disease on their own.
• G307S: a severe variant that completely knocks out enzyme function. People homozygous for this variant develop a non-B6-responsive, more aggressive form of homocystinuria.

Stroke and Brain Bleed Risk

Two CBS variants have human data tying them to bleeding and clotting in the brain. The C allele of T833C was associated with increased stroke risk in a meta-analysis, with the strongest signal in people of Chinese ancestry. The 844ins68 insertion allele was independently linked to aneurysmal subarachnoid hemorrhage in a study of around 200 adults, and a separate variant at rs234706 (the GG genotype) was tied to worse functional outcomes after that kind of brain bleed.

These associations are statistical, not deterministic. Carrying one of these variants does not mean a stroke is coming. It does mean that other modifiable risks, like blood pressure, smoking, and homocysteine itself, deserve more attention.

Heart Disease and Clot Risk

On its own, 844ins68 heterozygosity is not a clear risk factor for early heart attacks or vein clots. But it stops being neutral when combined with another common gene variant. People who carried both 844ins68 and the MTHFR 677TT genotype had roughly four times the risk of early-onset arterial and venous blockages compared to people without the combination, along with higher fasting homocysteine.

In people with classical homocystinuria caused by two damaging CBS mutations, the picture is more dramatic. Without treatment, roughly half of patients experienced a major vascular event by age 30. Long-term homocysteine-lowering treatment substantially reduces these vascular events, even when the homocysteine level does not fully normalize.

Sepsis and Other Disease Connections

A longer repeat sequence near another CBS variant (downstream of rs6586282) increased susceptibility to severe sepsis in a case-control study, with risk rising linearly with the number of tandem repeats. A single Chinese study found that mothers carrying the CBS 833TT genotype, especially when combined with an RFC-1 variant, had a 4.81-fold increased risk of having a child with Down syndrome, but larger meta-analyses have not confirmed CBS polymorphisms as a clear maternal risk factor for Down syndrome. In adult-onset X-linked adrenoleukodystrophy, the 844ins68 variant initially appeared protective against brain demyelination in one study, although a follow-up study in a larger group of patients did not reproduce this finding, so the protection is best treated as unconfirmed.

Why a Negative Result Does Not Rule Everything Out

Most genetic panels test a fixed list of CBS variants, typically the common polymorphisms and a few well-known mutations. Even when sequencing the full CBS gene, pathogenic variants are missed in a small percentage of people with biochemically confirmed CBS deficiency, because some changes hide in regions the test does not read well or get masked by amplification quirks.

This is why CBS genotyping should never be used alone to rule out a metabolic problem. Plasma total homocysteine is the better screen for functional impairment; the genotype tells you what kind of impairment is likely if homocysteine is elevated.

One-Time Test, Lifetime Information

Your CBS genotype is fixed from birth. You only need to test it once with a properly validated clinical assay. Retesting does not give new information. The value of this result comes from how it changes your monitoring and treatment over decades.

What does benefit from regular tracking is your homocysteine, which is influenced by your CBS genotype but also by B6, B12, folate, kidney function, and lifestyle. A reasonable approach, though not codified in formal guidelines, is to get a homocysteine baseline now, retest in 3 to 6 months if you make changes to diet or supplements, and at least annually after that. If you carry a CBS variant linked to higher disease risk, many clinicians also choose to track homocysteine alongside a full lipid workup, ApoB, and Lp(a) on the same cadence.

What an Unexpected Result Should Make You Do

If you discover you carry a CBS variant linked to homocystinuria (such as I278T or G307S) in a homozygous or compound heterozygous pattern, this is a medical finding, not a research curiosity. The pathway forward is direct: confirm with a second method (Sanger sequencing if the first test was a chip-based panel), measure plasma total homocysteine and methionine, and get a referral to a metabolic specialist. Treatment typically includes pyridoxine (vitamin B6), folate, B12, betaine, and dietary methionine restriction, with the specific mix determined by which variant you carry.

If you carry a single copy of a common variant such as 844ins68 or T833C, the workup is lighter. Measure your homocysteine. If it is elevated, check your MTHFR status, B12, folate, and kidney function. If homocysteine is normal, you do not need ongoing CBS-specific care, but the variant is worth noting in your record because it can interact with other risk factors over time.

Either way, share the result with biological family. Siblings have a 50 percent chance of carrying the same variant, children of an affected parent always inherit at least one copy of one parental variant, and partners of carriers of severe variants may want to be tested before having children.

What This Test Does Not Tell You

Carrying a CBS risk variant does not guarantee disease. Most people who carry a single copy of a common CBS polymorphism live without any related complication. Equally, a clean CBS report does not rule out homocysteine problems, because lifestyle, kidney function, and other genes (especially MTHFR) can push your homocysteine up regardless of your CBS sequence. The most useful way to think about your CBS result is as one input into a larger picture, alongside your blood markers and family history.